Exploiting synthetic lethality in PDAC with antibody drug conjugates and ATR inhibition

已完结 20 由 Chang 发布于 2025/8/5 9:44:13

DOI:10.1016/j.ejmech.2025.117305
作者：Tao Li , Xianqiang Yu , Xinyao Wan , Jing Liu , Jie Zheng , Ziyu Sun , Yi Zhao , Jiakang Chen , Hongli Chen , Yifeng Yang , Biao Jiang
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy with poor prognosis. Antibody-drug conjugates (ADCs) and their combinations with various anti-tumor drugs have made

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Preparation of Thin-Film Composite Membranes with Ultrahigh Mofs Loading Through Polymer-Template Mofs Induction Secondary Interfacial Polymerization